These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 1431095

  • 1. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.
    Dhein J, Daniel PT, Trauth BC, Oehm A, Möller P, Krammer PH.
    J Immunol; 1992 Nov 15; 149(10):3166-73. PubMed ID: 1431095
    [Abstract] [Full Text] [Related]

  • 2. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice.
    Schlesinger JJ, Foltzer M, Chapman S.
    Virology; 1993 Jan 15; 192(1):132-41. PubMed ID: 8517015
    [Abstract] [Full Text] [Related]

  • 3. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
    Masui H, Moroyama T, Mendelsohn J.
    Cancer Res; 1986 Nov 15; 46(11):5592-8. PubMed ID: 3756906
    [Abstract] [Full Text] [Related]

  • 4. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
    Steplewski Z, Lubeck MD, Scholz D, Loibner H, McDonald Smith J, Koprowski H.
    In Vivo; 1991 Nov 15; 5(2):79-83. PubMed ID: 1768791
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of human B-cell lymphoma by an anti-CD20 antibody and its chimeric F(ab')2 fragment via induction of apoptosis.
    Liu Y, Zheng M, Lai Z, Xiong D, Fan D, Xu Y, Peng H, Shao X, Xu Y, Yang M, Wang J, Liu H, Xie Y, Yang C, Zhu Z.
    Cancer Lett; 2004 Mar 18; 205(2):143-53. PubMed ID: 15036646
    [Abstract] [Full Text] [Related]

  • 6. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS, Kitamura K, Maloney DG, Campbell MJ, Levy R.
    J Immunol; 1986 Feb 01; 136(3):1123-30. PubMed ID: 3484499
    [Abstract] [Full Text] [Related]

  • 7. Influence of antibody isotype on passive serotherapy of lymphoma.
    Denkers EY, Badger CC, Ledbetter JA, Bernstein ID.
    J Immunol; 1985 Sep 01; 135(3):2183-6. PubMed ID: 2862210
    [Abstract] [Full Text] [Related]

  • 8. Comparison of GK1.5 and chimeric rat/mouse GK1.5 anti-CD4 antibodies for prolongation of skin allograft survival and suppression of alloantibody production in mice.
    Rashid A, Auchincloss H, Sharon J.
    J Immunol; 1992 Mar 01; 148(5):1382-8. PubMed ID: 1538121
    [Abstract] [Full Text] [Related]

  • 9. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
    Kummer U, Haunschild J, Reisbach G, Delecluse HJ, Thierfelder S.
    Eur J Immunol; 1993 Oct 01; 23(10):2649-54. PubMed ID: 8104797
    [Abstract] [Full Text] [Related]

  • 10. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells.
    Daniel PT, Krammer PH.
    J Immunol; 1994 Jun 15; 152(12):5624-32. PubMed ID: 7515909
    [Abstract] [Full Text] [Related]

  • 11. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y, Lubeck MD, Steplewski Z, Koprowski H.
    Cancer Res; 1984 Nov 15; 44(11):5127-31. PubMed ID: 6435864
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo.
    Drebin JA, Link VC, Greene MI.
    Oncogene; 1988 Apr 15; 2(4):387-94. PubMed ID: 2896329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism of inhibition and induction of cytolytic activity in cytotoxic T lymphocytes by CD3 monoclonal antibodies.
    van Seventer GA, Kuijpers KC, van Lier RA, de Groot ER, Aarden LA, Melief CJ.
    J Immunol; 1987 Oct 15; 139(8):2545-50. PubMed ID: 3498763
    [Abstract] [Full Text] [Related]

  • 15. Two distinct mechanisms of antitumor activity mediated by the combination of interleukin 2 and monoclonal antibodies.
    Vuist WM, van Buitenen F, Hekman A, Melief CJ.
    Cancer Res; 1990 Sep 15; 50(18):5767-72. PubMed ID: 1697500
    [Abstract] [Full Text] [Related]

  • 16. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK, Finkelman FD.
    J Immunol; 1988 May 01; 140(9):2919-24. PubMed ID: 2966202
    [Abstract] [Full Text] [Related]

  • 17. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
    Boot JH, Geerts ME, Aarden LA.
    J Immunol; 1989 Feb 15; 142(4):1217-23. PubMed ID: 2492577
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies.
    Spiridon CI, Guinn S, Vitetta ES.
    Clin Cancer Res; 2004 May 15; 10(10):3542-51. PubMed ID: 15161714
    [Abstract] [Full Text] [Related]

  • 19. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K, Kipps TJ, Yang HM, Cheresh DA, Wargalla U, Sander DJ, Reisfeld RA.
    Cancer Res; 1989 Jun 01; 49(11):2857-61. PubMed ID: 2720646
    [Abstract] [Full Text] [Related]

  • 20. B cell tolerance induction by cross-linking of membrane IgM, but not IgD, and synergy by cross-linking of both isotypes.
    Gaur A, Yao XR, Scott DW.
    J Immunol; 1993 Mar 01; 150(5):1663-9. PubMed ID: 8436810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.